Shanghai Medicilon (美迪西生物医药) is a contract research organization (CRO) that provides biopharmaceutical preclinical research and development solutions. Its services cover the whole process of preclinical new drug research, mainly including drug discovery, pharmaceutical research, and preclinical research. The company serves pharmaceutical and scientific research institutions.